3d systems announces sale of medical simulation business - simbionix

Rock hill, s.c., july 28, 2021 (globe newswire) -- 3d systems (nyse:ddd) today announced it has signed a definitive agreement to sell its medical simulation business, simbionix, to surgical science sweden ab (nasdaq first north growth market:sus), a leading supplier of virtual reality simulators for medical training, for a purchase price of $305 million, subject to customary closing conditions and adjustments. this action will complete 3d systems' initiative to divest non-core businesses in order to focus exclusively on its strategic purpose as the leader in enabling additive manufacturing solutions for applications in growing markets that demand high-reliability products.
DDD Ratings Summary
DDD Quant Ranking